NHS England

This page summarises the contracts and suppliers linked to this buyer in published notices. Values come from those notices.

Award history

Published records by year

Totals include values only when they can be added without obvious duplication. Framework totals and inconsistent values stay on their records but are not added here.

Annual award records and published values included in totals
Year	Awards	Value counted	Values not counted
2024	2	£1,402,124,948	0

Supplier relationships

Supplier relationships by value counted

Suppliers are ordered by published value assigned to one supplier, then by award count. Values shared between suppliers or marked as inconsistent are not assigned.

Public buyerNHS England

Published end dates

Contracts with end dates in the next 24 months

1 award.

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
Supplier: AMAROX LIMITED; Abbvie Ltd; DR REDDY'S LABORATORIES (UK) LIMITED; Gilead Sciences Limited; Janssen-Cilag Ltd; Lupin Healthcare (UK) Limited; MSN Laboratories Europe Limited; Macleods Pharma UK Limited; Mawdsley-Brooks & Co Ltd; Merck Sharpe & Dohme (UK) Limited; Milpharm Ltd/aurobinbdo Primary; Mylan; ViiV Healthcare UK Ltd
End date in notice
31 Oct 2026
Value shown in notice
£626,522,476Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-7ebc8e72-38c5-4910-9915-28bc0d6ff58a / ocds-b5fd17-7ebc8e72-38c5-4910-9915-28bc0d6ff58a-1

Published records by year

Supplier relationships by value counted

Contracts with end dates in the next 24 months

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024